MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • 2019 International Congress

    Predicting Impulse Control Disorders in Parkinson’s Disease: A Challenging Task

    J. Faouzi, S. Bekadar, O. Colliot, JC. Corvol (Paris, France)

    Objective: To predict the onset of impulse control disorders (ICDs) in Parkinson’s disease (PD) in several scenarios of interest for clinicians. Background: Impulse control disorders…
  • 2019 International Congress

    Subchronic copper exposure induces parkinsonism in rats: Neuromodulatory potential of curcumin

    A. Abbaoui, H. Gamrani (Marrakech, Morocco)

    Objective: We aim herein to assess the effect of subchronic Cu-intoxication (0.125%) for 6 weeks on the dopaminergic, serotonergic and astroglial systems together with behavioral…
  • 2019 International Congress

    Prospective study on impulsive-compulsive behaviours in early Parkinson’s disease

    V. Markovic, I. Stankovic, I. Petrovic, T. Stojkovic, V. Kostic (Belgrade, Serbia)

    Objective: To assess longitudinally impulsive-compulsive behaviours (ICBs) in a cohort of Parkinson's disease (PD) patients at the initial stage of the disease during 5 years…
  • 2019 International Congress

    Subacute Encephalopathy with Pimavanserin Treatment in Parkinson Disease

    J. King, G. Volkell, J. Wyant, E. Molho (Albany, NY, USA)

    Objective: To report 3 cases of drug-induced encephalopathy in patients treated with pimavanserin (PVN) for Parkinson disease (PD) related psychosis (PDP). Background: Quetiapine and clozapine,…
  • 2019 International Congress

    Shedding light on the relationship between dyskinesia assessed by a wearable device and impulsive compulsive behaviour in Parkinson’s disease

    F. Morgante, A. de Angelis, C. Siri, M. Horne, A. Leake, D. Paviour, M. Edwards, L. Ricciardi (London, United Kingdom)

    Objective: To evaluate the relationship between the presence of dyskinesia objectively detected using a wearable device and the presence of active and past impulsive compulsive…
  • 2019 International Congress

    Depression as a risk factor for impulse compulsive disorders in Parkinson’s disease: a prospective survival study

    J. Marín-Lahoz, F. Sampedro, S. Martinez-Horta, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To longitudinally evaluate the role of depression in the development of impulse control disorders (ICD) in Parkinson's disease (PD) patients. Background: Depression has been…
  • 2019 International Congress

    Diagnosis and management strategies used in series of Parkinson’s disease patients who experienced subthalamic nucleus deep brain stimulation induced mood elevation

    L. Spiegel, J. Weinstein, J. Ostrem, A. Seritan (San Francisco, CA, USA)

    Objective: To describe the diagnosis and management of deep brain stimulation-induced elevated mood states. Background: Deep brain stimulation (DBS) is an FDA-approved surgical treatment option…
  • 2019 International Congress

    The Urge to Move in Restless Legs Syndrome Associated with Parkinson’s Disease: A Motor Impulse Control Disorder?

    A. Marques, C. Lambert, T. Vidal, F. Durif, M. Fantini (Clermont-Ferrand, France)

    Objective: To determine whether there could be a semiological overlap between Restless Legs Syndrome (RLS) and Impulse Control Disorders (ICDs) in Parkinson’s Disease (PD), using…
  • 2019 International Congress

    Acute, contact-dependent behavioral changes in Parkinson disease (PD) patients during monopolar contact review of subthalamic deep brain stimulation (DBS) using directional leads

    CHR. Vander Linden, C. Bogaert, D. Colle, H. Colle (Ghent, Belgium)

    Objective: To describe distinctive acute behavioral changes that occurred during monopolar review in PD patients implanted with DBS directional leads, operated consecutively over 12 months.…
  • 2019 International Congress

    Disrupted salience network dynamics in Parkinson´s disease patients with impulse control disorders

    I. Navalpotro-Gomez, J. Kim, PM. Paz-Alonso, M. Delgado-Alvarado, A. Quiroga-Varela, H. Jimenez-Urbieta, M. Carreiras, AP. Strafella, MC. Rodriguez-Oroz (San Sebastian, Spain)

    Objective: Our aim was to investigate the changes in dynamic functional connectivity in the brain of such patients, as well as the topological properties. Background:…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley